Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis

Venetoclax is efficacious in relapsed/refractory t(11;14) multiple myeloma, thus warranting investigation in light-chain amyloidosis (AL). This retrospective cohort includes 43 patients with previously treated AL, from 14 centers in the US and Europe. Thirty-one patients harbored t(11;14), 11 did no...

Descripción completa

Detalles Bibliográficos
Autores principales: Premkumar, Vikram J., Lentzsch, Suzanne, Pan, Samuel, Bhutani, Divaya, Richter, Joshua, Jagannath, Sundar, Liedtke, Michaela, Jaccard, Arnaud, Wechalekar, Ashutosh D., Comenzo, Raymond, Sanchorawala, Vaishali, Royer, Bruno, Rosenzweig, Michael, Valent, Jason, Schönland, Stefan, Fonseca, Rafael, Wong, Sandy, Kapoor, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801694/
https://www.ncbi.nlm.nih.gov/pubmed/33431806
http://dx.doi.org/10.1038/s41408-020-00397-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801694/
https://www.ncbi.nlm.nih.gov/pubmed/33431806
http://dx.doi.org/10.1038/s41408-020-00397-w

Ejemplares similares